| Product NDC: | 58281-562 |
| Proprietary Name: | Lioresal |
| Non Proprietary Name: | baclofen |
| Active Ingredient(s): | .05 mg/mL & nbsp; baclofen |
| Administration Route(s): | INTRATHECAL |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 58281-562 |
| Labeler Name: | Medtronic Neuromodulation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020075 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19961107 |
| Package NDC: | 58281-562-01 |
| Package Description: | 1 AMPULE in 1 CARTON (58281-562-01) > 1 mL in 1 AMPULE |
| NDC Code | 58281-562-01 |
| Proprietary Name | Lioresal |
| Package Description | 1 AMPULE in 1 CARTON (58281-562-01) > 1 mL in 1 AMPULE |
| Product NDC | 58281-562 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | baclofen |
| Dosage Form Name | INJECTION |
| Route Name | INTRATHECAL |
| Start Marketing Date | 19961107 |
| Marketing Category Name | NDA |
| Labeler Name | Medtronic Neuromodulation |
| Substance Name | BACLOFEN |
| Strength Number | .05 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | GABA A Agonists [MoA],GABA B Agonists [MoA],gamma-Aminobutyric Acid-ergic Agonist [EPC] |